Frequency of elevations in markers of cardiomyocyte damage in otherwise healthy newborns
- PMID: 18774003
- PMCID: PMC2640933
- DOI: 10.1016/j.amjcard.2008.04.057
Frequency of elevations in markers of cardiomyocyte damage in otherwise healthy newborns
Abstract
Myocardial damage in infancy is a risk factor for eventual cardiac disease. Given that myocardial stress is greatest during the perinatal period and that the neonatal period is when most pediatric heart failure occurs, the aim of this study was to determine whether even otherwise healthy neonates might have subclinical myocardial damage and, if so, what characteristics might identify them. Umbilical cord and neonatal serum samples from 32 normal neonates were assayed for biomarkers of myocardial injury. No neonate had clinical evidence of cardiac or other abnormalities. Serum cardiac troponin T was elevated in 19 of 25 cords (76%) and in 16 of 17 neonates (94%); levels indicating myocardial infarction (> or =0.2 ng/ml) were found in 2 patients (1 umbilical cord and 1 neonatal sample). Creatine kinase-MB was elevated in 6 of 16 cords (38%) and in 8 of 15 neonates (53%). Cardiac troponin I was elevated in 11% and 17% of samples, myoglobin in 4% and 17%, and high-sensitivity C-reactive protein in 9% and 40%. Measures of myocardial injury were associated with longer hospitalization (r = 0.50, p = 0.04), non-Caucasian race (p = 0.012), lower birth weights (p = 0.014), positive maternal cervical cultures (r = 0.41, p = 0.046), and elevated high-sensitivity C-reactive protein (r = 0.66, p = 0.005). In conclusion, clinically occult myocardial injury appears to occur in some healthy newborns, although whether it is pathologic or not remains to be determined.
Similar articles
-
Cardiomyocyte injury induced by hemodynamic cardiac stress: Differential release of cardiac biomarkers.Clin Biochem. 2015 Dec;48(18):1225-9. doi: 10.1016/j.clinbiochem.2015.06.018. Epub 2015 Jun 27. Clin Biochem. 2015. PMID: 26129882 Clinical Trial.
-
Frequency of clinically unsuspected myocardial injury at a children's hospital.Am Heart J. 2006 Apr;151(4):916-22. doi: 10.1016/j.ahj.2005.06.029. Am Heart J. 2006. PMID: 16569563
-
Myocardial Injury Biomarkers in Newborns with Congenital Heart Disease.Pediatr Neonatol. 2016 Dec;57(6):488-495. doi: 10.1016/j.pedneo.2015.11.004. Epub 2016 Apr 2. Pediatr Neonatol. 2016. PMID: 27132548
-
Cardiac enzymes, renal failure and renal transplantation.Clin Med Res. 2006 Mar;4(1):79-84. doi: 10.3121/cmr.4.1.79. Clin Med Res. 2006. PMID: 16595795 Free PMC article. Review.
-
Cardiac injury biomarkers in paediatric age: Are we there yet?Heart Fail Rev. 2016 Nov;21(6):771-781. doi: 10.1007/s10741-016-9567-2. Heart Fail Rev. 2016. PMID: 27255332 Review.
Cited by
-
Cardiac biomarkers in HIV-exposed uninfected children.AIDS. 2013 Apr 24;27(7):1099-108. doi: 10.1097/QAD.0b013e32835cf21c. AIDS. 2013. PMID: 23211773 Free PMC article.
-
Cardiac myocyte proliferation and maturation near term is inhibited by early gestation maternal testosterone exposure.Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1393-H1401. doi: 10.1152/ajpheart.00314.2018. Epub 2018 Aug 10. Am J Physiol Heart Circ Physiol. 2018. PMID: 30095996 Free PMC article.
-
Cardiac Troponin T in Healthy Full-Term Infants.Pediatr Cardiol. 2019 Dec;40(8):1645-1654. doi: 10.1007/s00246-019-02199-9. Epub 2019 Sep 5. Pediatr Cardiol. 2019. PMID: 31489446 Free PMC article.
-
Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics.Pharmacol Rev. 2020 Jan;72(1):320-342. doi: 10.1124/pr.116.013003. Pharmacol Rev. 2020. PMID: 31871214 Free PMC article. Review.
-
Cardiac Function in Infants Born to Mothers With Gestational Diabetes - Estimation of Early Diastolic Intraventricular Pressure Differences.Circ Rep. 2019 Aug 28;1(9):378-388. doi: 10.1253/circrep.CR-19-0062. Circ Rep. 2019. PMID: 33693166 Free PMC article.
References
-
- El-Khuffash AF, Molloy EJ. Serum troponin in neonatal intensive care. Neonatology. 2008;94:1–7. - PubMed
-
- Lipshultz SE, Rifai N, Sallan SE, Lipsitz SR, Dalton V, Sacks DB, Ottlinger ME. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation. 1997;96:2641–2648. - PubMed
-
- Lipshultz SE, Rifai N, Dalton VM, Levy DE, Silverman LB, Lipsitz SR, Colan SD, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Gelber RD, Sallan SE. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med. 2004;351:145–153. - PubMed
-
- Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647–1655. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous